Pityriasis Rubra Pilaris Significantly Improved after Treatment for Chronic Focal Infection.
作者信息
Ishikawa Masato, Igari Shohei, Hiraiwa Tomoko, Hanami Yuka, Yamamoto Toshiyuki
机构信息
Department of Dermatology, Fukushima Medical University, Fukushima, Japan E-mail:
出版信息
Indian J Dermatol. 2022 Sep-Oct;67(5):626. doi: 10.4103/ijd.ijd_1016_20.
Abstract
摘要
相似文献
1
Pityriasis Rubra Pilaris Significantly Improved after Treatment for Chronic Focal Infection.
Indian J Dermatol. 2022 Sep-Oct;67(5):626. doi: 10.4103/ijd.ijd_1016_20.
2
Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis.
Br J Dermatol. 2022 Nov;187(5):650-658. doi: 10.1111/bjd.21708. Epub 2022 Jul 15.
3
Pityriasis rubra pilaris: a review of diagnosis and treatment.
J Am Acad Dermatol. 1989 May;20(5 Pt 1):801-7. doi: 10.1016/s0190-9622(89)70093-1.
4
Pityriasis rubra pilaris and HIV infection.
J Am Acad Dermatol. 1991 May;24(5 Pt 1):703-5. doi: 10.1016/0190-9622(91)70106-c.
5
Surgical Management of Cicatricial Ectropion in Pityriasis Rubra Pilaris.
Ophthalmic Plast Reconstr Surg. 2016 Jan-Feb;32(1):e12-5. doi: 10.1097/IOP.0000000000000385.
6
[Multiple basaliomas in pityriasis rubra pilaris].
Hautarzt. 1979 Oct;30(10):537-9.
7
Dermatomyositis with a pityriasis rubra pilaris-like eruption: an uncommon cutaneous manifestation in dermatomyositis.
Pediatr Dermatol. 2007 Mar-Apr;24(2):151-4. doi: 10.1111/j.1525-1470.2007.00364.x.
8
Pityriasis rubra pilaris heralding diagnosis of urothelial carcinoma: a case report.
Dermatol Online J. 2022 Aug 15;28(4). doi: 10.5070/D328458518.
9
Systemic sclerosis in a patient with pityriasis rubra pilaris.
Pan Afr Med J. 2010 Aug 9;6:6. doi: 10.4314/pamj.v6i1.69070.
10
Pityriasis rubra pilaris.
Dermatol Online J. 2003 Oct;9(4):6.
引用本文的文献
1
Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris.
Nat Commun. 2024 Jul 24;15(1):6259. doi: 10.1038/s41467-024-50481-z.
2
Pityriasis Rubra Pilaris: An Updated Review of Clinical Presentation, Etiopathogenesis, and Treatment Options.
Am J Clin Dermatol. 2024 Mar;25(2):243-259. doi: 10.1007/s40257-023-00836-x. Epub 2023 Dec 30.
本文引用的文献
1
Case of pityriasis rubra pilaris progressed to generalized erythroderma following blockade of interleukin-17A, but improved after blockade of interleukin-12/23 p40.
J Dermatol. 2019 Jan;46(1):70-72. doi: 10.1111/1346-8138.14709. Epub 2018 Dec 3.
2
Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris.
JAMA Dermatol. 2017 Apr 1;153(4):304-308. doi: 10.1001/jamadermatol.2016.5384.
3
Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis.
J Autoimmun. 2012 Dec;39(4):294-303. doi: 10.1016/j.jaut.2012.03.003. Epub 2012 May 3.
4
Pityriasis rubra pilaris with preceding cytomegalovirus infection.
Dermatology. 2009;219(4):350-2. doi: 10.1159/000240018. Epub 2009 Sep 17.
5
Lymphocyte response to superantigen in a patient with childhood-onset pityriasis rubra pilaris.
Int J Dermatol. 1999 Aug;38(8):639-40.
Zotero 插件